New Key Statistics Module, Z-Score and F-Score
NAS:ICPT Key Ratios
| Market Cap $ M | 794.69 |
| Enterprise Value $ M | 695.84 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 7.87 |
| Price/Book | 11.06 |
| Price/Sales | 2.49 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 317.00 |
| EPS (TTM) $ | -1.48 |
| Beneish M-Score | -2.34 |
| 10-y EBITDA Growth Rate % | -0.20 |
| 5-y EBITDA Growth Rate % | 23.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -14.43 |
| EV-to-EBITDA | -14.54 |
| PEG | -- |
| Shares Outstanding M | 41.83 |
| Net Margin (%) | -19.39 |
| Operating Margin % | -17.34 |
| Pre-tax Margin (%) | -18.09 |
| Quick Ratio | 4.22 |
| Current Ratio | 4.22 |
| ROA % (ttm) | -12.35 |
| ROE % (ttm) | -75.63 |
| ROIC % (ttm) | -45.44 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.97 |
ICPT Number of Guru Trades
ICPT Volume of Guru Trades
Gurus Latest Trades with NAS:ICPT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ICPT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Intercept Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ICPT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers